Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. cancerous target
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Magazines
Downloads
Videos

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals

Cancerous Target Suppliers & Manufacturers

37 companies found

Vor Biopharma

Vor Biopharma

based inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
Hematopoietic Stem Cell Transplant Treatment

Hematopoietic Stem Cell Transplant Treatment

The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a ...
CONTACT SUPPLIER

Traws Pharma

Traws Pharma

based inNewtown, PENNSYLVANIA (USA)
Formely known as Onconova Therapeutics, Inc. Traws Pharma is a clinical stage biopharmaceutical company developing small molecule oral product candidates for respiratory viral diseases and cancer. In the viral respiratory disease space, Traws Pharma ...
Onconova - Rigosertib - Small Molecule

Onconova - Rigosertib - Small Molecule

Rigosertib is a small molecule that inhibits multiple cellular signaling pathways driving cancer cell growth while having little effect on normal cells. In contrast to many kinase inhibitors, rigosertib does not interact at the ATP binding site, but ...
CONTACT SUPPLIER

CDR-Life

CDR-Life

based inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
Antibody Therapies

Antibody Therapies

CDR-Life’s T cell engaging antibodies are potentially transformative in the field of cancer immunotherapies» Prof. Markus G. Manz, MD, Head of Medical Oncology and Hematology at University Hospital and University of ...
CONTACT SUPPLIER

Context Therapeutics Inc.

Context Therapeutics Inc.

based inPhiladelphia, PENNSYLVANIA (USA)
Context is dedicated to developing the next generation of therapies to treat solid tumors, with a primary focus on female cancers. Female cancers include breast, ovarian, and endometrial cancer. To target these cancers, we are advancing bispecific ...
CONTACT SUPPLIER

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics Ltd.

based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
CONTACT SUPPLIER

Akrotome Imaging, Inc.

Akrotome Imaging, Inc.

based inCleveland, OHIO (USA)
Advances in cancer diagnostics have enabled the detection of cancer at its earliest stages when the chances for successful intervention are highest. For many tumors, surgery offers the best option for a cure, with the potential to remove all cancer ...
CONTACT SUPPLIER

Kura Oncology, Inc.

Kura Oncology, Inc.

based inSan Diego, CALIFORNIA (USA)
At Kura Oncology, we are committed to realizing the promise of precision medicines for the treatment of cancer. The genomics revolution is transforming how we treat cancer. We now understand that a patient’s response to treatment depends in part on ...
Kura Oncology - Precision Medicines

Kura Oncology - Precision Medicines

With the advent of precision medicines that can target unique molecular or genetic features of a patient’s tumor, the field of oncology has a host of alternatives to one-size-fits-all treatments. This is a major advance over ...
CONTACT SUPPLIER

Epichem Pty Ltd

Epichem Pty Ltd

based inBentley, AUSTRALIA
Based in Perth, Western Australia, Epichem was established in 2003 and was driven by a desire to solve difficult synthetic chemistry problems and to provide jobs for home grown PhD organic chemists. We are Australia’s leading provider of synthetic ...
CONTACT SUPPLIER

Vitanova Biomedical, Inc. (VNB)

Vitanova Biomedical, Inc. (VNB)

based inKerrville, TEXAS (USA)
Vitanova Biomedical, Inc. (VNB) is a San Antonio, TX-based early stage biotechnology company developing patented (pending) technology licensed from the University of Texas at San Antonio. The company’s cancer treatment, Light-Activated Intracellular ...
Vitanova - Light-Activated Intracellular Acidosis (LAIA)

Vitanova - Light-Activated Intracellular Acidosis (LAIA)

Vitanova Biomedical’s Cancer Therapy Technology Platform is Called Light-Activated Intracellular Acidosis (LAIA). Vitanova Biomedical (VNB) has developed a proprietary energy-based technique to elicit ...
CONTACT SUPPLIER

Universal Diagnostics SL

Universal Diagnostics SL

based inSeville, SPAIN
We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden ...
CONTACT SUPPLIER

Scancell

Scancell

based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

Glycosylation is a post-translational modification that occurs inside the cell and results in the addition of sugar motifs, “glycans”, to proteins and lipids that are, in most cases, destined for the cell surface. These glycan structures ...
CONTACT SUPPLIER

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

based inSan Diego, CALIFORNIA (USA)
We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19. Cancer is genetically diverse, highly adaptive, constantly mutating and virtually invisible to ...
CONTACT SUPPLIER

Nuclidium AG

Nuclidium AG

based inBasel, SWITZERLAND
Nuclidium AG specializes in leveraging the unique properties of copper radionuclides in conjunction with tumor-specific molecules to enhance the precision, performance, and accessibility of targeted radiotherapy and diagnostics. Their proprietary ...
Nuclidium CuTrace - Platform for Targeted Radiotherapy and Diagnostics

Nuclidium CuTrace - Platform for Targeted Radiotherapy and Diagnostics

Their proprietary CuTrace™ platform combines copper nuclides with tumor-specific molecules, creating diagnostic and therapeutic pairs designed to optimize the safety and efficacy profile in cancer treatment. These ...
CONTACT SUPPLIER

Respiratory Research, Inc.

Respiratory Research, Inc.

based inAustin, TEXAS (USA)
Breath science is rapidly growing — and we are growing with it Advances in analytical chemistry have accelerated the pace of exhaled biomarker research. New breath diagnostics targeting cancer, asthma, infections, and other conditions are rapidly ...
CONTACT SUPPLIER

Elthera AG

Elthera AG

based inSchlieren, SWITZERLAND
Elthera AG is a Swiss biopharmaceutical company founded in 2016 by experienced Pharma and Biotech executives with the goal of developing proprietary, first-in-class oncology drugs using a personalized health care approach. Elthera AG is developing ...
CONTACT SUPPLIER

Reglagene Holding, Inc.

Reglagene Holding, Inc.

based inTucson, ARIZONA (USA)
Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better ...
Reglagene - Novel Therapeutics Lacking for Brain Cancer

Reglagene - Novel Therapeutics Lacking for Brain Cancer

Only 4 of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009, but this medicine did not extend life expectancy. Patients deserve better therapies that extend life and ...
CONTACT SUPPLIER

Lightpoint Medical, Ltd

Lightpoint Medical, Ltd

based inWaterside, UNITED KINGDOM
Lightpoint Medical is a technology leader in targeted cancer surgery. We are developing miniaturized imaging and sensing tools for more precise intra-operative cancer detection. Our mission is to improve the lives of people with cancer by ...
Sensei - Targeted Cancer Surgery Advanced Guidance System

Sensei - Targeted Cancer Surgery Advanced Guidance System

An advanced guidance system designed for intracavity radio-guided surgery. The miniaturized SENSEI® probe enables unprecendented dexterity and anatomic reach, expanding the field of view and enabling the quick localization of radioactive ...
CONTACT SUPPLIER

MtoZ Biolabs

MtoZ Biolabs

based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
MtoZ Biolabs - Gene Knockout for Drug Screening and Target Identification

MtoZ Biolabs - Gene Knockout for Drug Screening and Target Identification

A key step in drug discovery is target identification—identifying "druggable" biological targets. After a target is identified, it must be validated to demonstrate the functional relationship between the target and disease phenotype while ensuring ...
CONTACT SUPPLIER

bioMérieux S.A.

bioMérieux S.A.

based inMarcy l`Etoile, FRANCE
Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. A family-owned company, bioMérieux has grown to become a world leader in the ...
CONTACT SUPPLIER

Taiho Oncology, Inc.

Taiho Oncology, Inc.

based inPrinceton, NEW JERSEY (USA)
Taiho Oncology, Inc. specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT